Protective effect of VK2 on glucocorticoid-treated MC3T3-E1 cells.
Protective effect of VK2 on glucocorticoid-treated MC3T3-E1 cells.
复制标题
VK2对糖皮质激素处理的MC3T3-E1细胞的保护作用
DOI:
10.3892/ijmm.2016.2817
复制
发表时间:
2017-01
影响因子:
5.4
通讯作者:
Gao YS
中科院分区:
文献类型:
--
作者:
Zhang YL;Yin JH;Ding H;Zhang W;Zhang CQ;Gao YS
Glucocorticoids (GCs) contribute to the increased incidence of secondary osteoporosis and osteonecrosis, and medications for the prevention and treatment of these complications have been investigated for many years. Vitamin K2 (VK2) has been proven to promote bone formation both in vitro and in vivo. In this study, we examined the effects of VK2 on dexamethasone (DEX)-treated MC3T3-E1 osteoblastic cells. We observed that VK2 promoted the proliferation and enhanced the survival of dexamethasone-treated MC3T3-E1 cells. In addition, VK2 upregulated the expression levels of osteogenic marker proteins, such as Runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteocalcin, which were significantly inhibited by dexamethasone. On the whole, our findings indicate that VK2 has the potential to antagonize the effects of GCs on MC3T3-E1 cells, and may thus prove to be a promising agent for the prevention and treatment of GC-induced osteoporosis and osteonecrosis.
登录
查看更多内容
影响因子:
11.2
作者:
Kirane A;Ludwig KF;Sorrelle N;Haaland G;Sandal T;Ranaweera R;Toombs JE;Wang M;Dineen SP;Micklem D;Dellinger MT;Lorens JB;Brekken RA
通讯作者:
Brekken RA
DOI:
10.1302/0301-620x.86b8.14834
发表时间:
2004-11-01
影响因子:
--
作者:
Calder, JDF;Buttery, L;Polak, JM
通讯作者:
Polak, JM
影响因子:
1.6
作者:
Koitaya, Noriko;Ezaki, Junko;Ishimi, Yoshiko
通讯作者:
Ishimi, Yoshiko
影响因子:
15.9
作者:
Manolagas, Stavros C.
通讯作者:
Manolagas, Stavros C.
影响因子:
5.3
作者:
Igarashi, Mamoru;Yogiashi, Yoshiko;Kato, Shigeaki
通讯作者:
Kato, Shigeaki